Cases 11 - 20 of 76
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00632
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc., et al.
as 1:2019cv00315
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2018cv01699
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al
as 1:2018cv01562
Plaintiff:
AstraZeneca Pharmaceuticals LP and AstraZeneca AB
Defendant:
Mylan Inc., Mylan N.V., Mylan Laboratories Limited and others
Cause Of Action: 35 U.S.C. § 271
Noven Pharmaceuticals, Inc. v. Mylan Technologies Inc. et al
as 1:2017cv01777
Plaintiff:
Noven Pharmaceuticals, Inc.
Defendant:
Mylan Technologies Inc. , Mylan Pharmaceuticals Inc. , Mylan Inc. and others
Cause Of Action: 35 U.S.C. § 271
UCB, Inc. et al v. Mylan Technologies, Inc. et al
as 1:2017cv00322
Plaintiff:
UCB, Inc. , UCB Manufacturing Ireland Limited , UCB Pharma GmbH and others
Defendant:
Mylan Technologies, Inc. , Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Counter_claimant:
Mylan Pharmaceuticals, Inc. , Mylan Technologies, Inc. and Mylan, Inc.
Counter_defendant:
LTS Lohmann Therapie-Systeme AG , UCB Manufacturing Ireland Limited , UCB Pharma GmbH and others
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals USA, Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2017cv00249
Plaintiff:
Teva Pharmaceuticals USA, Inc. , Teva Pharmaceutical Industries Ltd. and Teva Neuroscience, Inc.
Defendant:
Mylan Pharmaceuticals Inc. , Mylan Inc. and Natco Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2017cv00113
Plaintiff:
Amgen Inc.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Mylan Pharmaceuticals Inc. et al
as 1:2017cv00024
Plaintiff:
Sanofi-Aventis U.S. LLC , Aventisub LLC , Sanofi and others
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
